IMMU-10. INTERIM ANALYSIS OF THE HIT-HGG REZ IMMUNVAC STUDY - DENDRITIC CELL VACCINATION WITH PARTIAL TREG DEPLETION IN CHILDREN, ADOLESCENTS, AND ADULTS WITH RELAPSED HIGH-GRADE GLIOMAS

Efficacy of therapeutic dendritic cell vaccines (DCV) can be limited by immunosuppressive mechanisms in the micromilieu of high-grade gliomas. In the HIT-HGG-Rez Immunovac trial (Eudra-CT 2013-000419-26), we investigate whether a reduction of Treg with metronomic cyclophosphamide (metrCyc) might be...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuro Oncol
Glavni autori: Eyrich, Matthias, Krauss, Jürgen, Rachor, Johannes, Monoranu, Camelia, Bison, Brigitte, Löhr, Mario, Rückriegel, Stefan, Wölfl, Matthias, Miller, Elisabeth, Schlegel, Paul G, Kramm, Christof
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Immunotherapy
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715918/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.366
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items